Objective: To explore the efficacy of continuous circulating hyperthermic intrathoracic chemotherapy at a temperature of 42-43°C for malignant pleural effusion.
2025-02-11
Objective: To evaluate the clinical efficacy of early application of intraperitoneal perfusion machine for intraperitoneal circulation hyperthermic perfusion chemotherapy after gastric cancer surgery.
2025-02-11
Objective: To observe the clinical efficacy of loop thermal infusion chemotherapy in the treatment of malignant ascites.
2025-02-11
Objective: This study mainly analyzes and discusses the efficacy of circulating hyperthermic perfusion chemotherapy in patients with advanced gastric cancer complicated by ascites, in order to provide a reference for the clinical treatment of such patients.
2025-02-11
Good Doctor·Hot Infusion Q&A Manual
Good Doctor·Thermal Infusion is a specialized medical technology company that is a pioneer in the continuous circulation thermal infusion treatment technology, integrating research and development, registration, production, and sales.
2025-02-11
Objective: To observe the effectiveness and safety of abdominal cavity circulation hyperperfusion combined with chemotherapy in the treatment of advanced gastric cancer with abdominal effusion.
2025-02-10
Evaluate the impact of intraperitoneal hyperthermic chemotherapy (IPHC) on the immune function of patients with gastrointestinal malignancies. Method: After surgery, 32 patients with gastrointestinal malignancies underwent intraperitoneal hyperthermic chemotherapy, and the peripheral blood T lymphocyte subsets were measured.
2022-08-26
Overall, compared to developed countries, China's medical device industry still has gaps in quality, quantity, and technological level. China's medical device industry only accounts for 3% of the global market, which is far from meeting the needs of our health and wellness sector.
2022-08-26
Malignant pleural and abdominal effusion is one of the common complications in the late stage of malignant tumors. It not only worsens the condition but also severely affects the quality of life of patients. Our department treated 82 patients with intrathoracic and intra-abdominal hyperthermic perfusion chemotherapy using hydroxytaxanes and cisplatin from 1998 to 2003.
2022-08-26